sclareol has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hongjuan, M; Li, W; Minglian, L; Ping, Z; Xuemei, G; Yi, H; Zhongxiang, Z | 1 |
| Cai, P; Wang, T; Zhang, T | 1 |
2 other study(ies) available for sclareol and Cancer of Cervix
| Article | Year |
|---|---|
Naturally Occurring Sclareol Diterpene Augments the Chemosensitivity of Human Hela Cervical Cancer Cells by Inducing Mitochondrial Mediated Programmed Cell Death, S-Phase Cell Cycle Arrest and Targeting Mitogen-Activated Protein Kinase (MAPK)/Extracellula
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Shape; Diterpenes; Female; HeLa Cells; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; S Phase; Uterine Cervical Neoplasms | 2020 |
Sclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Caveolin 1; Cell Line, Tumor; Cell Proliferation; Diterpenes; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Lysosomes; Proteolysis; Superoxide Dismutase-1; Uterine Cervical Neoplasms | 2017 |